Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
February 15, 2018
Reward motivation in humans and its relationship to dopamine D<sub>2/3</sub> receptor availability: A pilot study with dual [<sup>11</sup>C]-raclopride and [<sup>11</sup>C]-(+)-PHNO imaging
Fernando Caravaggio, Gagan Fervaha, Caleb J Browne, et al.
Journal of Clinical Psychopharmacology
|
August 13, 2015
The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 18, 2015
What does schizophrenia teach us about antipsychotics?
Gary Remington, Ofer Agid, George Foussias, et al.
JAMA Psychiatry
|
July 31, 2014
Motivational deficits and cognitive test performance in schizophrenia
Gagan Fervaha, Konstantine K Zakzanis, George Foussias, et al.
The Journal of Clinical Psychiatry
|
May 3, 2016
Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al.
Current Treatment Options in Psychiatry
|
July 5, 2016
Treating Negative Symptoms in Schizophrenia: an Update
Gary Remington, George Foussias, Gagan Fervaha, et al.
Journal of Psychiatric Research
|
September 3, 2013
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
Gagan Fervaha, Ariel Graff-Guerrero, Konstantine K Zakzanis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 9, 2015
Antipsychotics and amotivation
Gagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
The Journal of Clinical Psychiatry
|
February 27, 2014
Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data
Hiroyoshi Takeuchi, Gagan Fervaha, Hiroyuki Uchida, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Journal of Psychopharmacology (Oxford, England)
|
February 15, 2018
Reward motivation in humans and its relationship to dopamine D<sub>2/3</sub> receptor availability: A pilot study with dual [<sup>11</sup>C]-raclopride and [<sup>11</sup>C]-(+)-PHNO imaging
Fernando Caravaggio, Gagan Fervaha, Caleb J Browne, et al.
Journal of Clinical Psychopharmacology
|
August 13, 2015
The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 18, 2015
What does schizophrenia teach us about antipsychotics?
Gary Remington, Ofer Agid, George Foussias, et al.
JAMA Psychiatry
|
July 31, 2014
Motivational deficits and cognitive test performance in schizophrenia
Gagan Fervaha, Konstantine K Zakzanis, George Foussias, et al.
The Journal of Clinical Psychiatry
|
May 3, 2016
Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al.
Current Treatment Options in Psychiatry
|
July 5, 2016
Treating Negative Symptoms in Schizophrenia: an Update
Gary Remington, George Foussias, Gagan Fervaha, et al.
Journal of Psychiatric Research
|
September 3, 2013
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
Gagan Fervaha, Ariel Graff-Guerrero, Konstantine K Zakzanis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 9, 2015
Antipsychotics and amotivation
Gagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
The Journal of Clinical Psychiatry
|
February 27, 2014
Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data
Hiroyoshi Takeuchi, Gagan Fervaha, Hiroyuki Uchida, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
Page
of 10